Lactate/GPR81 recruits regulatory T cells by modulating CX3CL1 to promote immune resistance in a highly glycolytic gastric cancer

References

• Ngwa VM, Edwards DN, Philip M, Chen J. Microenvironmental Metabolism Regulates Antitumor Immunity. Cancer Res. 2019;79(16):4003–17. doi:10.1158/0008-5472.CAN-19-0617.
   PubMed Web of Science ®Google Scholar
• Chandel NS. Glycolysis. Cold Spring Harb Perspect Biol. 2021;13(5):a040535. doi:10.1101/cshperspect.a040535.
   PubMed Web of Science ®Google Scholar
• Liberti MV, Locasale JW. The Warburg effect: how does it benefit cancer cells? Trends Biochem Sci. 2016;41(3):211–218. doi:10.1016/j.tibs.2015.12.001.
   PubMed Web of Science ®Google Scholar
• Rabinowitz JD, Enerbäck S. Lactate: the ugly duckling of energy metabolism. Nat Metab. 2020;2(7):566–571. doi:10.1038/s42255-020-0243-4.
   PubMedGoogle Scholar
• Certo M, Tsai CH, Pucino V, Ho PC, Mauro C. Lactate modulation of immune responses in inflammatory versus tumour microenvironments. Nat Rev Immunol. 2021;21(3):151–161. doi:10.1038/s41577-020-0406-2.
   PubMed Web of Science ®Google Scholar
• Ippolito L, Morandi A, Giannoni E, Chiarugi P. Lactate: a metabolic driver in the tumour landscape. Trends Biochem Sci. 2019;44(2):153–166. doi:10.1016/j.tibs.2018.10.011.
   PubMed Web of Science ®Google Scholar
• García-Cañaveras JC, Chen L, Rabinowitz JD. The Tumor Metabolic Microenvironment: Lessons from Lactate. Cancer Res. 2019;79(13):3155–3162. doi:10.1158/0008-5472.CAN-18-3726.
   PubMed Web of Science ®Google Scholar
• Xie D, Zhu S, Bai L. Lactic acid in tumor microenvironments causes dysfunction of NKT cells by interfering with mTOR signaling. Sci China Life Sci. 2016;59(12):1290–1296. doi:10.1007/s11427-016-0348-7.
   PubMed Web of Science ®Google Scholar
• Roland CL, Arumugam T, Deng D, Liu SH, Philip B, Gomez S, Burns WR, Ramachandran V, Wang H, Cruz-Monserrate Z. et al. Cell surface lactate receptor GPR81 is crucial for cancer cell survival. Cancer Res. 2014;74(18):5301–5310. doi:10.1158/0008-5472.CAN-14-0319.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Li M, Yao X, Fei Y, Lin Z, Li Z, Cai K, Zhao Y, Luo Z. GPR81/MCT1 regulates tumor ferroptosis through the Lactate-Mediated AMPK-SCD1 activity and its therapeutic implications. Cell Rep. 2020;33(10):108487. doi:10.1016/j.celrep.2020.108487.
   PubMed Web of Science ®Google Scholar
• Kumagai S, Koyama S, Itahashi K, Tanegashima T, Lin YT, Togashi Y, Kamada T, Irie T, Okumura G, Kono H. et al. Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments. Cancer Cell. 2022;40(2):201–218. doi:10.1016/j.ccell.2022.01.001.
   PubMed Web of Science ®Google Scholar
• Lundø K, Trauelsen M, Pedersen SF, Schwartz TW. Why Warburg Works: lactate controls immune evasion through GPR81. Cell Metab. 2020;31(4):666–668. doi:10.1016/j.cmet.2020.03.001.
   PubMed Web of Science ®Google Scholar
• Sathe A, Grimes SM, Lau BT, Chen J, Suarez C, Huang RJ, Poultsides G, Ji HP. Single-cell genomic characterization reveals the cellular reprogramming of the gastric tumor microenvironment. Clin Cancer Res. 2020;26(11):2640–2653. doi:10.1158/1078-0432.CCR-19-3231.
   PubMed Web of Science ®Google Scholar
• Zheng Y, Chen Z, Han Y, Han L, Zou X, Zhou B, Hu R, Hao J, Bai S, Xiao H. et al. Immune suppressive landscape in the human esophageal squamous cell carcinoma microenvironment. Nat Commun. 2020;11(1):6268. doi:10.1038/s41467-020-20019-0.
   PubMed Web of Science ®Google Scholar
• Su J, Guo W, Chen Z, Wang L, Liu H, Zhao L, Lin T, Li F, Mao X, Huang H. et al. Safety and short-term outcomes of laparoscopic surgery for advanced gastric cancer after neoadjuvant immunotherapy: a retrospective cohort study. Front Immunol. 2022;13:1078196. doi:10.3389/fimmu.2022.1078196.
   PubMed Web of Science ®Google Scholar
• Janjigian YY, Shitara K, Moehler M, Garrido M, Salman P, Shen L, Wyrwicz L, Yamaguchi K, Skoczylas T, Campos Bragagnoli A. et al. First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial. Lancet. 2021;398(10294):27–40. doi:10.1016/S0140-6736(21)00797-2.
   PubMed Web of Science ®Google Scholar
• Tay C, Tanaka A, Sakaguchi S. Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy. Cancer Cell. 2023;41(3):450–465. doi:10.1016/j.ccell.2023.02.014.
   PubMed Web of Science ®Google Scholar
• Lee JC, Mehdizadeh S, Smith J, Young A, Mufazalov IA, Mowery CT. et al. Regulatory T cell control of systemic immunity and immunotherapy response in liver metastasis. Sci Immunol. 2020;5(52):eaba0759. doi:10.1126/sciimmunol.aba0759.
   PubMed Web of Science ®Google Scholar
• Bessede A, Marabelle A, Guégan JP, Danlos FX, Cousin S, Peyraud F, Chaput N, Spalato M, Roubaud G, Cabart M. et al. Impact of acetaminophen on the efficacy of immunotherapy in cancer patients. Ann Oncol. 2022;33(9):909–915. doi:10.1016/j.annonc.2022.05.010.
   PubMed Web of Science ®Google Scholar
• De Simone M, Arrigoni A, Rossetti G, Gruarin P, Ranzani V, Politano C, Bonnal RP, Provasi E, Sarnicola M, Panzeri I. et al. Transcriptional landscape of human tissue lymphocytes unveils uniqueness of tumor-infiltrating T regulatory cells. Immunity. 2016;45(5):1135–1147. doi:10.1016/j.immuni.2016.10.021.
   PubMed Web of Science ®Google Scholar
• Togashi Y, Shitara K, Nishikawa H. Regulatory T cells in cancer immunosuppression - implications for anticancer therapy. Nat Rev Clin Oncol. 2019;16(6):356–371. doi:10.1038/s41571-019-0175-7.
   PubMed Web of Science ®Google Scholar
• Wang D, Yang L, Yu W, Wu Q, Lian J, Li F, Liu S, Li A, He Z, Liu J. et al. Colorectal cancer cell-derived CCL20 recruits regulatory T cells to promote chemoresistance via FOXO1/CEBPB/NF-κB signaling. J Immunother Cancer. 2019;7(1):215. doi:10.1186/s40425-019-0701-2.
   PubMed Web of Science ®Google Scholar
• Hoelzinger DB, Smith SE, Mirza N, Dominguez AL, Manrique SZ, Lustgarten J. Blockade of CCL1 inhibits T regulatory cell suppressive function enhancing tumor immunity without affecting T effector responses. J Immunol. 2010;184(12):6833–6842. doi:10.4049/jimmunol.0904084.
   PubMed Web of Science ®Google Scholar
• Tan MC, Goedegebuure PS, Belt BA, Flaherty B, Sankpal N, Gillanders WE, Eberlein TJ, Hsieh C-S, Linehan DC. Disruption of CCR5-dependent homing of regulatory T cells inhibits tumor growth in a murine model of pancreatic cancer. J Immunol. 2009;182(3):1746–1755. doi:10.4049/jimmunol.182.3.1746.
   PubMed Web of Science ®Google Scholar
• Gobert M, Treilleux I, Bendriss-Vermare N, Bachelot T, Goddard-Leon S, Arfi V, Biota C, Doffin AC, Durand I, Olive D. et al. Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome. Cancer Res. 2009;69(5):2000–2009. doi:10.1158/0008-5472.CAN-08-2360.
   PubMed Web of Science ®Google Scholar
• Ji L, Qian W, Gui L, Ji Z, Yin P, Lin GN, Wang Y, Ma B, Gao W-Q. Blockade of β-Catenin–Induced CCL28 suppresses gastric cancer progression via inhibition of Treg cell infiltration. Cancer Res. 2020;80(10):2004–2016. doi:10.1158/0008-5472.CAN-19-3074.
   PubMed Web of Science ®Google Scholar
• Rogers AB, Taylor NS, Whary MT, Stefanich ED, Wang TC, Fox JG. Helicobacter pylori but not high salt induces gastric intraepithelial neoplasia in B6129 mice. Cancer Res. 2005;65(23):10709–10715. doi:10.1158/0008-5472.CAN-05-1846.
   PubMed Web of Science ®Google Scholar
• Liu W, Putnam AL, Xu-Yu Z, Szot GL, Lee MR, Zhu S, Gottlieb PA, Kapranov P, Gingeras TR, de St. Groth BF. et al. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med. 2006;203(7):1701–1711. doi:10.1084/jem.20060772.
   PubMed Web of Science ®Google Scholar
• Marshall LA, Marubayashi S, Jorapur A, Jacobson S, Zibinsky M, Robles O, Hu DX, Jackson JJ, Pookot D, Sanchez J. et al. Tumors establish resistance to immunotherapy by regulating Treg recruitment via CCR4. J Immunother Cancer. 2020;8(2):e000764. doi:10.1136/jitc-2020-000764.
   PubMed Web of Science ®Google Scholar
• Huo S, Luo Y, Deng R, Liu X, Wang J, Wang L, Zhang B, Wang F, Lu J, Li X. et al. EBV-EBNA1 constructs an immunosuppressive microenvironment for nasopharyngeal carcinoma by promoting the chemoattraction of Treg cells. J Immunother Cancer. 2020;8(2):e001588. doi:10.1136/jitc-2020-001588.
   PubMed Web of Science ®Google Scholar
• De La Rochere P, Guil-Luna S, Decaudin D, Azar G, Sidhu SS, Piaggio E. Humanized mice for the study of immuno-oncology. Trends Immunol. 2018;39(9):748–763. doi:10.1016/j.it.2018.07.001.
   PubMed Web of Science ®Google Scholar
• Wang YA, Li XL, Mo YZ, Fan CM, Tang L, Xiong F, Guo C, Xiang B, Zhou M, Ma J. et al. Effects of tumor metabolic microenvironment on regulatory T cells. Mol Cancer. 2018;17(1):168. doi:10.1186/s12943-018-0913-y.
   PubMed Web of Science ®Google Scholar
• Nagase H, Takeoka T, Urakawa S, Morimoto-Okazawa A, Kawashima A, Iwahori K, Takiguchi S, Nishikawa H, Sato E, Sakaguchi S. et al. ICOS+ Foxp3+ TILs in gastric cancer are prognostic markers and effector regulatory T cells associated with Helicobacter pylori. Int J Cancer. 2017;140(3):686–695. doi:10.1002/ijc.30475.
   PubMed Web of Science ®Google Scholar
• Sun S, Li H, Chen J, Qian Q. Lactic acid: No Longer an Inert and end-product of Glycolysis. Physiol (Bethesda). 2017;32(6):453–463. doi:10.1152/physiol.00016.2017.
   PubMed Web of Science ®Google Scholar
• Walenta S, Schroeder T, Mueller-Klieser W. Lactate in solid malignant tumors: potential basis of a metabolic classification in clinical oncology. Curr Med Chem. 2004;11(16):2195–2204. doi:10.2174/0929867043364711.
   PubMed Web of Science ®Google Scholar
• Faubert B, Li KY, Cai L, Hensley CT, Kim J, Zacharias LG, Yang C, Do QN, Doucette S, Burguete D. et al. Lactate Metabolism in Human Lung Tumors. Cell. 2017;171(2):358–371.e9. doi:10.1016/j.cell.2017.09.019.
   PubMed Web of Science ®Google Scholar
• Liu N, Luo J, Kuang D, Xu S, Duan Y, Xia Y, Wei Z, Xie X, Yin B, Chen F. et al. Lactate inhibits ATP6V0d2 expression in tumor-associated macrophages to promote HIF-2α–mediated tumor progression. J Clin Invest. 2019;129(2):631–646. doi:10.1172/JCI123027.
   PubMed Web of Science ®Google Scholar
• Girgis H, Masui O, White NM, Scorilas A, Rotondo F, Seivwright A, Gabril M, Filter ER, Girgis AH, Bjarnason GA. et al. Lactate dehydrogenase A is a potential prognostic marker in clear cell renal cell carcinoma. Mol Cancer. 2014;13(1):101. doi:10.1186/1476-4598-13-101.
   PubMedGoogle Scholar
• Brand A, Singer K, Koehl GE, Kolitzus M, Schoenhammer G, Thiel A, Matos C, Bruss C, Klobuch S, Peter K. et al. LDHA-Associated lactic acid production blunts tumor immunosurveillance by T and NK Cells. Cell Metab. 2016;24(5):657–671. doi:10.1016/j.cmet.2016.08.011.
   PubMed Web of Science ®Google Scholar
• Hong CS, Graham NA, Gu W, Espindola Camacho C, Mah V, Maresh EL, Alavi M, Bagryanova L, Krotee PAL, Gardner BK. et al. MCT1 modulates cancer cell pyruvate export and growth of tumors that Co-express MCT1 and MCT4. Cell Rep. 2016;14(7):1590–1601. doi:10.1016/j.celrep.2016.01.057.
   PubMed Web of Science ®Google Scholar
• Polański R, Hodgkinson CL, Fusi A, Nonaka D, Priest L, Kelly P, Trapani F, Bishop PW, White A, Critchlow SE. et al. Activity of the monocarboxylate transporter 1 inhibitor AZD3965 in small cell lung cancer. Clin Cancer Res. 2014;20(4):926–937. doi:10.1158/1078-0432.CCR-13-2270.
   PubMed Web of Science ®Google Scholar
• Brown TP, Bhattacharjee P, Ramachandran S, Sivaprakasam S, Ristic B, Sikder MOF, Ganapathy V. The lactate receptor GPR81 promotes breast cancer growth via a paracrine mechanism involving antigen-presenting cells in the tumor microenvironment. Oncogene. 2020;39(16):3292–3304. doi:10.1038/s41388-020-1216-5.
   PubMed Web of Science ®Google Scholar
• Yang X, Lu Y, Hang J, Zhang J, Zhang T, Huo Y, Liu J, Lai S, Luo D, Wang L. et al. Lactate-modulated immunosuppression of myeloid-derived suppressor cells contributes to the radioresistance of pancreatic cancer. Cancer Immunol Res. 2020;8(11):1440–1451. doi:10.1158/2326-6066.CIR-20-0111.
   PubMed Web of Science ®Google Scholar
• Feng J, Yang H, Zhang Y, Wei H, Zhu Z, Zhu B, Yang M, Cao W, Wang L, Wu Z. et al. Tumor cell-derived lactate induces TAZ-dependent upregulation of PD-L1 through GPR81 in human lung cancer cells. Oncogene. 2017;36(42):5829–5839. doi:10.1038/onc.2017.188.
   PubMed Web of Science ®Google Scholar
• Nishikawa H, Koyama S. Mechanisms of regulatory T cell infiltration in tumors: implications for innovative immune precision therapies. J Immunother Cancer. 2021;9(7):e002591. doi:10.1136/jitc-2021-002591.
   PubMed Web of Science ®Google Scholar
• Gajewski TF, Corrales L, Williams J, Horton B, Sivan A, Spranger S. Cancer immunotherapy targets based on understanding the T Cell-Inflamed versus Non-T Cell-Inflamed tumor Microenvironment. Adv Exp Med Biol. 2017;1036:19–31. doi:10.1007/978-3-319-67577-0_2
   PubMed Web of Science ®Google Scholar
• Kumagai S, Koyama S, Nishikawa H. Antitumour immunity regulated by aberrant ERBB family signalling. Nat Rev Cancer. 2021;21(3):181–197. doi:10.1038/s41568-020-00322-0.
   PubMed Web of Science ®Google Scholar
• Serrels A, Lund T, Serrels B, Byron A, McPherson RC, von Kriegsheim A, Gómez-Cuadrado L, Canel M, Muir M, Ring J. et al. Nuclear FAK controls chemokine transcription, tregs, and evasion of anti-tumor immunity. Cell. 2015;163(1):160–173. doi:10.1016/j.cell.2015.09.001.
   PubMed Web of Science ®Google Scholar
• Isse K, Harada K, Zen Y, Kamihira T, Shimoda S, Harada M, Nakanuma Y. Fractalkine and CX3CR1 are involved in the recruitment of intraepithelial lymphocytes of intrahepatic bile ducts. Hepatology. 2005;41(3):506–516. doi:10.1002/hep.20582.
   PubMed Web of Science ®Google Scholar
• Lee S, Latha K, Manyam G, Yang Y, Rao A, Rao G. Role of CX3CR1 signaling in malignant transformation of gliomas. Neuro Oncol. 2020;22(10):1463–1473. doi:10.1093/neuonc/noaa075.
   PubMed Web of Science ®Google Scholar
• Yu SJ, Ma C, Heinrich B, Brown ZJ, Sandhu M, Zhang Q, Fu Q, Agdashian D, Rosato U, Korangy F. et al. Targeting the crosstalk between cytokine-induced killer cells and myeloid-derived suppressor cells in hepatocellular carcinoma. J Hepatol. 2019;70(3):449–457. doi:10.1016/j.jhep.2018.10.040.
   PubMed Web of Science ®Google Scholar
• Chen EB, Zhou ZJ, Xiao K, Zhu GQ, Yang Y, Wang B, Zhou S-L, Chen Q, Yin D, Wang Z. et al. The miR-561-5p/CX3CL1 Signaling Axis Regulates Pulmonary Metastasis in Hepatocellular Carcinoma Involving CX3CR1+ Natural Killer Cells Infiltration. Theranostics. 2019;9(16):4779–4794. doi:10.7150/thno.32543.
   PubMed Web of Science ®Google Scholar
• Baldwin AS. Regulation of cell death and autophagy by IKK and NF-κB: critical mechanisms in immune function and cancer. Immunol Rev. 2012;246(1):327–345. doi:10.1111/j.1600-065X.2012.01095.x.
   PubMedGoogle Scholar
• Peng C, Ouyang Y, Lu N, Li N. The NF-κB signaling pathway, the microbiota, and Gastrointestinal Tumorigenesis: recent advances. Front Immunol. 2020;11:1387. doi:10.3389/fimmu.2020.01387.
   PubMed Web of Science ®Google Scholar
• Nagumo Y, Kandori S, Tanuma K, Nitta S, Chihara I, Shiga M, Hoshi A, Negoro H, Kojima T, Mathis BJ. et al. PLD1 promotes tumor invasion by regulation of MMP-13 expression via NF-κB signaling in bladder cancer. Cancer Lett. 2021;511:15–25. doi:10.1016/j.canlet.2021.04.014.
   PubMed Web of Science ®Google Scholar
• Lu W, Zhang G, Zhang R, Flores LG, Huang Q, Gelovani JG, Li C. Tumor site–specific silencing of NF-κB p65 by targeted hollow gold nanosphere–mediated photothermal transfection. Cancer Research. 2010;70(8):3177–3188. doi:10.1158/0008-5472.CAN-09-3379.
   PubMed Web of Science ®Google Scholar